AICare

AICare examines the challenges on Swedish healthcare regulation posed by artificial intelligence, aiming to enhance it and safeguard the right to health.

  • Period: 2021-01-01 – 2026-12-31
  • Budget: 6,000,000 SEK
  • Funder: Marcus and Amalia Wallenberg Foundation, Marianne and Marcus Wallenberg Foundation

AI, automated systems & the right to health

Health emergencies not only result in personal tragedies but also have profound economic implications, sometimes with severe social consequences. Artificial intelligence (AI) can help address these challenges by facilitating the discovery of new cures treatments. AI can help enhance the planning of and timely response to healthcare needs, optimising the overall quality of healthcare, and at the same time reducing costs. AI also has the potential to free up medical staff from administrative and routine tasks, and allows increased patient participation.

The integration of digital technology in healthcare and the initiation of AI pilot projects are already tangible realities in Sweden. But the implementation of AI in healthcare faces legal challenges. The absence of specific laws and the significant uncertainty about the application of existing rules to new technology can become obstacles to innovation. Ensuring that AI healthcare solutions are universally available and accessible without discrimination, acceptable to patients, and adhere to quality standards to prevent privacy breaches, errors, malfunctions, or malicious acts is crucial.

Addressing these challenges, the AICare project focuses on examining the impact of AI on the right to health in the Swedish context. The project evaluates key elements of the right to health — availability, accessibility, acceptability, and quality — and its intersection with other fundamental rights. Taking into account the empirical insights from patients and healthcare professionals, AICare explores how AI challenges existing legal and ethical norms governing healthcare in Sweden. The project aims to propose viable solutions, whether through the revision or reinterpretation of current rules or the introduction of new measures. The overarching goal is to promote technological advancements while ensuring robust patient protection.

  • Lund University, Sweden
  • Uppsala University's Centre for Research Ethics & Bioethics, Sweden
  • KTH Royal Institute of Technology, Sweden
  • Linköping University, Sweden

People in the project

Project leader: Anna Nordberg, Lund University , Jennifer Viberg Johansson, Uppsala University's Centre for Research Ethics & Bioethics
Co-investigators: Amal Matar, Uppsala University's Centre for Research Ethics & Bioethics, Ana Nordberg, Lund University, Jennifer Viberg Johansson, Uppsala University's Centre for Research Ethics & Bioethics, Santa Slokenberga, Uppsala University's Department of Law, Sara de Heer, Lund University, Michele Farisco, Uppsala University's Centre for Research Ethics & Bioethics
Further members can be found in the University directory.

FOLLOW UPPSALA UNIVERSITY ON

facebook
instagram
twitter
youtube
linkedin